[	O
Interleukin	O
-	O
18	O
and	O
new	O
drugs	O
.	O
Protective	O
effect	O
against	O
tumor	B-Cancer
growth	O
and	O
infections	O
]	O
.	O

IL	O
-	O
18	O
,	O
originally	O
identified	O
as	O
interferon	O
-	O
gamma	O
inducing	O
factor	O
(	O
IGIF	O
)	O
,	O
is	O
related	O
to	O
the	O
IL	O
-	O
1	O
family	O
in	O
terms	O
of	O
its	O
structure	O
as	O
well	O
as	O
its	O
processing	O
,	O
receptor	O
,	O
signal	O
transduction	O
pathway	O
and	O
pro	O
-	O
inflammatory	O
properties	O
.	O

IL	O
-	O
18	O
is	O
also	O
functionally	O
related	O
to	O
IL	O
-	O
12	O
,	O
as	O
it	O
induces	O
the	O
production	O
of	O
Th1	O
cytokines	O
and	O
participates	O
in	O
cell	B-Cell
-	O
mediated	O
immune	O
cytotoxicity	O
.	O

A	O
summary	O
is	O
made	O
of	O
recent	O
advances	O
in	O
the	O
understanding	O
of	O
IL	O
-	O
18	O
structure	O
,	O
processing	O
,	O
receptor	O
expression	O
and	O
immunoregulatory	O
functions	O
.	O

It	O
focuses	O
on	O
the	O
role	O
of	O
IL	O
-	O
18	O
modulation	O
in	O
tumours	B-Cancer
,	O
infections	O
and	O
autoimmune	O
and	O
inflammatory	O
diseases	O
.	O

